D.J. Girling

6.9k citations

73 papers · 4.6k indexed · 1 hit paper · h-index 33

Impact in

Pulmonary and Respiratory Medicine top 0.5%
- Gastric Cancer Management and Outcomes
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
Oncology top 2%
- Lung Cancer Research Studies

Papers in

Oncology 31
- Lung Cancer Research Studies 19
- Cancer survivorship and care 8
Infectious Diseases 15
- Tuberculosis Research and Epidemiology 14

Co-authors: Richard Stephens David Machin Penelope Hopwood Peter Fayers N. M. Bleehen Andrew Nunn Fergus Macbeth Wallace Fox
Journals: Lung Cancer (7 papers)Clinical Oncology (7 papers)The Lancet (7 papers)British Journal of Cancer (5 papers)European Journal of Cancer (4 papers)
Partner nations: United Kingdom China Singapore

In The Last Decade

D.J. Girling

70 papers receiving 4.3k citations

Hit Papers

align trajectories log scale

Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial 2002 · 1.1k citations

Peers

Countries citing papers authored by D.J. Girling

Since Specialization

Citations

This map shows the geographic impact of D.J. Girling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.J. Girling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.J. Girling more than expected).

Fields of papers citing papers by D.J. Girling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.J. Girling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.J. Girling. The network helps show where D.J. Girling may publish in the future.

Co-authors

The 25 scholars most cited alongside D.J. Girling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D.J. Girling Line = papers co-authored together D.J. Girling links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Multicenter randomized controlled trial of the management of unresectable malignant mesothelioma proposed by the British Thoracic Society and the British Medical Research Council Seminars in Oncology ·D.J. Girling, Martin F. Muers, Wendi Qian, Patricia Sierra Casas	2002	13
2	A national survey of the chemotherapy regimens used to treat small cell lung cancer (SCLC) in the United Kingdom British Journal of Cancer ·R Sambrook, D.J. Girling	2001	19
3	Radiotherapy for Inoperable Lung Cancer Clinical Oncology ·A.R. Timothy, D.J. Girling, M.I. Saunders, Fergus Macbeth, Peter Hoskin	2001	8
4	Important issues in planning and conducting multi-centre randomised trials in cancer and publishing their results Critical Reviews in Oncology/Hematology ·D.J. Girling	2000	2
5	Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial European Journal of Cancer ·A. Gregor, A. Cull, Richard Stephens, John A. Kirkpatrick, John Yarnold, D.J. Girling, Fergus Macbeth, R. Stout, David Machin	1997	260
6	Quality of life assessment in clinical trials—guidelines and a checklist for protocol writers: the U.K. Medical Research Council experience European Journal of Cancer ·Peter Fayers, P. Hopwood, A Harvey, D.J. Girling, David Machin, Richard Stephens	1997	122
7	Randomized trials with quality of life endpoints: Are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings? Quality of Life Research ·Richard Stephens, Penelope Hopwood, D.J. Girling, David Machin	1997	197
8	Radiation myelopathy: Estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer Clinical Oncology ·Fergus Macbeth, T. E. Wheldon, D.J. Girling, Richard Stephens, David Machin, N. M. Bleehen, Alan Lamont, David Radstone, Nick Reed	1996	65
9	Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status Clinical Oncology ·Fergus Macbeth, Quarra-Tul-Ain, Penelope Hopwood, N M Bleehen, Cornelis Vaandrager, D.J. Girling, David Machin, Richard Stephens, A.J. Bailey	1996	160
10	The feasibility of using glycosylated recombinant human granulocyte colonystimulating factor (G-CSF) to increase the planned dose intensity of doxorubicin; cyclophosphamide and etoposide (ACE) in the treatment of small cell lung cancer European Journal of Cancer ·N. Thatcher, Helén Anderson, N. M. Bleehen, D.J. Girling, Taylor D. Cecil, David Machin	1995	12
11	Increasing and planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) by adding recombinant human methionyl granulocyte colony-stimulating factor (G-CSF; filgrastim) in the treatment of small cell lung cancer (SCLC) Clinical Oncology ·N. Thatcher, Richard Sanchez-Albornoz, İsmet Yüksel, Francisco Suarez Cardona, D.J. Girling, David Machin, Richard Stephens, Taylor D. Cecil, Bonnie Jenkins	1995	8
12	Treatment-related deaths in small cell lung cancer trials: can patients at risk be identified? Lung Cancer ·Richard Stephens, D.J. Girling, David Machin	1994	30
13	Does clinical experience with a treatment regimen affect survival of lung cancer patients? An analysis based on consecutive randomized trials of the medical research council in small cell and non-small cell tumours Clinical Oncology ·Sai Priyanjali Chintala, David Machin, Michael J. Campbell, Richard Stephens, N. M. Bleehen, D.J. Girling	1994	5
14	A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Working Party. British Journal of Cancer ·N. M. Bleehen, D.J. Girling, David Machin, Richard Stephens, Nick Thatcher	1992	90
15	Double blind controlled trial of chemoprophylaxis against tuberculosis in patients with silicosis in hong kong American Review of Respiratory Disease ·D.J. Girling	1990	0
16	Serodiagnosis of Tuberculosis Using an ELISA with Antigen 5 and a Hemagglutination Assay with Glycolipid Antigens: Results in Patients with Newly Diagnosed Pulmonary Tuberculosis Ranging in Extent of Disease from Minimal to Extensive American Review of Respiratory Disease ·Stephen L. Chan, Z Reggiardo, Thomas M. Daniel, D.J. Girling, D.A. Mitchison	1990	28
17	Controlled trial of twelve versus six courses of chemotherapy in the treatment of small-cell lung cancer. Report to the Medical Research Council by its Lung Cancer Working Party British Journal of Cancer ·N. M. Bleehen, Peter Fayers, D.J. Girling, Richard Stephens	1989	78
18	HLA Typing in the Hong Kong Chest Service/British Medical Research Council Study of Factors Associated with the Breakdown to Active Tuberculosis of Inactive Pulmonary Lesions American Review of Respiratory Disease ·B. R. Hawkins, Deborah Higgins, Stephen L. Chan, Douglas B. Lowrie, D A Mitchison, D.J. Girling	1988	26
19	CONTROLLED CLINICAL TRIAL OF COMPLETE OPEN SURGICAL DRAINAGE AND OF PREDNISOLONE IN TREATMENT OF TUBERCULOUS PERICARDIAL EFFUSION IN TRANSKEI The Lancet ·J.I.G. Strang, D G Gibson, D.A. Mitchison, D.J. Girling, Roberto Noguez Hernández, B.W. Allen, David Evans, Andrew Nunn, Wallace Fox	1988	118
20	Acute leukaemia after busulphan. BMJ ·H Stott, Wallace Fox, D.J. Girling, RJ Stephens, D. A. G. Galton	1977	58

About D.J. Girling

D.J. Girling is a scholar working on Oncology, Infectious Diseases, Pharmacology, Epidemiology and Pulmonary and Respiratory Medicine, having authored 73 papers that have together received 4.6k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (19 papers), Tuberculosis Research and Epidemiology (14 papers), Cancer therapeutics and mechanisms (10 papers), Lung Cancer Treatments and Mutations (10 papers), Neuroendocrine Tumor Research Advances (10 papers), Lung Cancer Diagnosis and Treatment (9 papers), Mycobacterium research and diagnosis (8 papers) and Cancer survivorship and care (8 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.3k citations), Oncology (1.4k citations), Surgery (1.8k citations), Otorhinolaryngology (154 citations) and Epidemiology (1.0k citations). D.J. Girling has collaborated with scholars based in United Kingdom, China and Singapore. Frequent co-authors include Richard Stephens, David Machin, Penelope Hopwood, Peter Fayers, N. M. Bleehen, Andrew Nunn, Fergus Macbeth, Wallace Fox, R Sambrook and J.I.G. Strang. Their work appears in journals such as Lung Cancer, Clinical Oncology, The Lancet, British Journal of Cancer and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact